Contact this trialFirst, we need to learn more about you.
Procedure
Corneal Crosslinking +1 More for Keratoconus
Recruiting2 awardsPhase 2
Montréal, Quebec
This trial tests whether applying a small amount of mitomycin C to the eye can reduce cloudiness and scarring in patients with early-stage corneal disorders who have had corneal crosslinking. The goal is to improve their vision quality by reducing inflammation and scarring. Mitomycin C has been widely used in various eye procedures to minimize scarring and improve outcomes, demonstrating effectiveness in reducing haze and scarring in several studies.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service